Filing Flows › Amphastar Pharmaceuticals (AMPH) › Net income
Amphastar Pharmaceuticals (AMPH) net income by quarter
Amphastar Pharmaceuticals' net income was $37.8M in Q3 2026 (third quarter 2026), +24% from Q2 2026. Over the last 7 quarters it ranged from $6.4M (Q1 2026) to $37.8M (Q3 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $37.8M | +24% | +118% |
| Q2 2026 | $30.3M | +373% | -2% |
| Q1 2026 | $6.4M | -74% | -75% |
| Q4 2025 | $24.4M | +41% | — |
| Q3 2025 | $17.4M | -44% | — |
| Q2 2025 | $31.0M | +23% | — |
| Q1 2025 | $25.3M | — | — |
Q3 2026 at a glance
Amphastar Pharmaceuticals, Q3 2026: revenue $208M (+8% year over year), operating margin 24.5%, net earnings $37.8M, operating cash flow $43.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Amphastar Pharmaceuticals' net income?
Amphastar Pharmaceuticals' net income was $37.8M in Q3 2026 (third quarter 2026), +24% from Q2 2026.
How has Amphastar Pharmaceuticals' net income changed?
Over the last 7 quarters it ranged from $6.4M (Q1 2026) to $37.8M (Q3 2026).
Q3 2026 results → · How Amphastar Pharmaceuticals makes money →